SCHEMBL6169323

SCHEMBL6169323

CC(=O)Nc1ccc(C(=O)NS(=O)(=O)c2ccccc2)cc1[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.56
PKM P14618 2/20 0.56
HCAR3 P49019 1/20 0.54
ALDH1A1 P00352 5/20 0.53
GAA P10253 2/20 0.53
KMT2A Q03164 1/20 0.53
BCL2 P10415 3/20 0.52
BCL2L1 Q07817 3/20 0.52
MCL1 Q07820 3/20 0.52
MAPT P10636 4/20 0.50
TDP1 Q9NUW8 1/20 0.50
FBP1 P09467 3/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
NPC1 O15118 2/20 0.48
MAPK1 P28482 2/20 0.48
RAB9A P51151 2/20 0.48
GLA P06280 1/20 0.48
CASP3 P42574 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170355 0.84 ALDH1A1 (0.48) POLBPKMALDH1A1GAAKMT2A
SCHEMBL3645755 0.82 KMT2A (0.65) HCAR3ALDH1A1GAAKMT2AMAPT
SCHEMBL6168346 0.81 KMT2A (0.51) ALDH1A1KMT2ALMNAHPGDNPC1
SCHEMBL6170460 0.80 FLT1 (0.47) POLBALDH1A1GAAKMT2ABCL2
SCHEMBL6169439 0.80 KMT2A (0.50) ALDH1A1KMT2ALMNAHPGDNPC1
SCHEMBL11150919 0.79 HCAR3 (0.63) HCAR3ALDH1A1KMT2AMAPTNPSR1
SCHEMBL3613079 0.78 HCAR3 (0.72) HCAR3KMT2AMAPTNPSR1
SCHEMBL6171844 0.78 MAPK1 (0.59) GAAKMT2ABCL2BCL2L1MCL1
SCHEMBL14106469 0.77 KMT2A (0.56) ALDH1A1GAAKMT2ABCL2BCL2L1
SCHEMBL6168841 0.77 KMT2A (0.57) POLBPKMHCAR3ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed